lobbying_activities: 1992114

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1992114	a0d66aa1-63d0-4e8b-a168-d34ddd1e1de8	Q2	ALKERMES, INC.	400458235	ALKERMES, INC.	2017	second_quarter	PHA	Public law #114-198, Cures Opioid Funding Implementation H.R. 2430 FDA Reauthorization Act of 2017 S.934 FDA Reauthorization Act of 2017	Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Veterans Affairs, Dept of (VA)		940000	0	0	2017-07-18T14:36:56.847000-04:00